Author name: ZasAdmin

ZAS Corporation Obtains Trademark for Protimeal Brand

We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand Protimeal. Registered under trademark no. 216979, effective from November 15, 2017, this certification covers all goods under class 30. This achievement highlights our dedication to protecting the integrity of our products and ensuring that Protimeal continues to provide trusted

ZAS Corporation Obtains Trademark for Protimeal Brand Read More »

ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh

We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our commitment to advancing healthcare in the nation. This launch represents not just the introduction of new treatments but the beginning of a new era in patient care, driven by innovation and quality. Our launch campaign

ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh Read More »

Productive Meetings & Promising Partnerships in Philippines.

The Philippine business tour proved to be a uniquely successful experience, highlighted by productive meetings and promising partnerships. Enthusiastically anticipating the potential for business expansion in the Philippines. As we depart from this vibrant landscape, we carry with us not only the memories of productive exchanges but also a renewed sense of enthusiasm for the

Productive Meetings & Promising Partnerships in Philippines. Read More »

ZAS Divisional Heads Unite for ‘Towards Tomorrow’ Visioning Session

In a momentous gathering at ZAS, divisional heads came together for an inspiring ‘Towards Tomorrow – A Collective Visioning Session.’ Led by the Chairman and Managing Director, alongside visionary leaders, the event marked a pivotal occasion as the course for future goals was charted. With a shared vision to redefine success and innovation, the leaders

ZAS Divisional Heads Unite for ‘Towards Tomorrow’ Visioning Session Read More »

ZAS Pharma Ltd.’s Managing Director, Md. Zahidul Islam, Spearheads Advancements in Glaucoma Care at the 14th Annual BGS Conference in Vietnam.

In a significant stride towards advancing eye healthcare, Md. Zahidul Islam, the Managing Director of ZAS Pharma Ltd., recently participated in the 14th Annual National Conference of the Bangladesh Glaucoma Society (BGS) held in Vietnam. The event served as a pivotal platform for professionals and experts in the field of ophthalmology to exchange knowledge and

ZAS Pharma Ltd.’s Managing Director, Md. Zahidul Islam, Spearheads Advancements in Glaucoma Care at the 14th Annual BGS Conference in Vietnam. Read More »

ZAS Pharma Unveils Fresh and New Website to Elevate Healthcare Experience.

ZAS Pharma is thrilled to announce the launch of its cutting-edge website, www.zaspharma.com.bd, marking a significant stride in the pursuit of global healthcare excellence. Devoted to the dissemination of top-notch medicines, our platform aims to reach every corner of the world. Join us in commemorating this momentous occasion as our dedicated export team passionately embarks

ZAS Pharma Unveils Fresh and New Website to Elevate Healthcare Experience. Read More »

ZAS Revolutionizes Respiratory Health with Groundbreaking Scientific Session.

ZAS marked a historic milestone by hosting the inaugural Scientific Session at Hotel Radisson Blu Dhaka, focusing on the preventive potential of Lyophilized Bacterial Lysates for Recurrent Respiratory Tract Infections. The event showcased the newly launched Broncho-Vaxom, a revolutionary lyophilized bacterial lysate with a precise 7mg dosage. Attended by distinguished ICU, Respiratory Medicine, Pediatrician, and

ZAS Revolutionizes Respiratory Health with Groundbreaking Scientific Session. Read More »

A successful conclusion of CPHI Barcelona & the start of exciting new opportunities!

The conclusion of CPHI Barcelona signifies not just the end of an event but the dawn of exciting new opportunities for ZAS. This milestone marks the commencement of a journey filled with intensive networking and productivity, solidifying powerful connections with industry innovators. With an expanded global network as a foundation, ZAS is now strategically positioned

A successful conclusion of CPHI Barcelona & the start of exciting new opportunities! Read More »

ZAS Pharma Ltd. commemorates Epilepsy Awareness Month in November 2023 with the esteemed doctors of BSMMU.

ZAS Pharma Ltd. proudly observes Epilepsy Awareness Month in November 2023, collaborating with the esteemed doctors of Bangabandhu Sheikh Mujib Medical University through their ‘Named Patient Access’ initiative. In a collective effort, they aim to heighten awareness about rare diseases, offering crucial support to those facing these challenges. Heartfelt gratitude is extended to the dedicated

ZAS Pharma Ltd. commemorates Epilepsy Awareness Month in November 2023 with the esteemed doctors of BSMMU. Read More »

Scroll to Top

Send us your query